Maytenus laevis
Maytenus laevis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Maytenus laevis is a botanical species that has gained significant interest in pharmacological research. Studies have highlighted its potential antitumor activities, offering hope for new cancer treatment developments. A key chemical constituent identified in this plant is canophyllol, which contributes to its biological efficacy. Researchers often utilize the methanol extract of the bark to isolate these potent bioactive compounds. Understanding these properties provides valuable insight into the medicinal potential of this unique plant.
- Synonyms
- Monteverdia Sapotiformis · Maytenus Sapotiformis · 2 more
- Common names
- Not available
- Family
- Celastraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Maytenus laevis is a botanical species that is identified through several distinct taxonomic synonyms. Within various scientific records, this plant is also referred to by the name Maytenus jauaensis. Additionally, the species has been historically cataloged under the synonym Maytenus sapotiformis. Taxonomic shifts have also linked the plant to the genus Monteverdia, specifically as Monteverdia laevis. Finally, the name Monteverdia sapotiformis serves as another recognized synonym within its complex nomenclatural history.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Maytenus laevis is a distinct botanical species belonging to the kingdom Plantae. Within this vast biological kingdom, it is classified under the class Equisetopsida. This plant further belongs to the order Celastrales, showcasing its specific evolutionary lineage. It is a member of the family Celastraceae, which provides key insight into its structural characteristics. Finally, its taxonomic identity is solidified by its placement within the genus Maytenus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Celastrales |
| Family | Celastraceae |
| Genus | Maytenus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Maytenus laevis is a notable plant species with a broad geographic presence across the South American continent. Its natural distribution spans several key regions, including large portions of Brazil and its northern territories. The species is also commonly found throughout Northern South America, specifically within the borders of Guyana and Venezuela. Furthermore, its reach extends into Western South America, where it thrives in the landscapes of Colombia. This diverse range highlights the plant's ability to inhabit various ecological niches across the region.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Maytenus laevis is a self-supporting plant that typically takes the form of a tree. It grows to a maximum height of approximately 7 meters. This distinctive growth habit makes it a notable feature within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Maytenus laevis is a medicinal plant native to Colombia that has recently come under scientific scrutiny for its potential therapeutic properties. Researchers investigated the methanol extract of its bark, successfully identifying six new compounds alongside 28 known constituents. During the study, several of these isolated compounds were screened for their ability to induce cytokines in human peripheral blood mononuclear cells. This process was specifically designed to evaluate the plant's potential antitumor activity. Among the findings, the compound canophyllol emerged as the most effective agent in stimulating these crucial immune responses.
Compounds
Maytenus laevis is a medicinal plant native to Colombia that has been extensively studied for its diverse chemical constituents. Researchers analyzed methanol extracts from its bark, successfully identifying twenty-eight known compounds along with six previously undiscovered structures. Among these various chemical components, the presence of canophyllol was specifically highlighted during the investigation. This particular compound was screened for its ability to induce cytokines in human peripheral blood mononuclear cells to evaluate potential antitumor effects. Ultimately, canophyllol demonstrated the most significant effectiveness in cytokine induction compared to the other substances tested.
Conditions
Preparations
Maytenus laevis is prepared as a methanol extract of the bark to facilitate the study of its chemical constituents. This specific preparation process yielded six new compounds and 28 known compounds during chemical analysis. Researchers utilized spectroscopic evidence to successfully elucidate the structures of these extracted substances. Some of these identified compounds were further screened for their cytokine-inducing activity on human PBMCs. Among the results, canophyllol demonstrated the most effective induction of cytokines within the bark extract.